Erkko Ylösmäki
- Biotechnology top 2%
- Genetics top 5%
- Virus-based gene therapy research 14
- Oncology top 10%
- CAR-T cell therapy research 12
- Immunology top 10%
- Immunotherapy and Immune Responses 12
- interferon and immune responses 2
-
- RNA Interference and Gene Delivery 6
- Viral Infectious Diseases and Gene Expression in Insects 4
- vaccines and immunoinformatics approaches 4
-
- Viral gastroenteritis research and epidemiology 2
Erkko Ylösmäki
27 papers receiving 996 citations
Peers
Comparison fields: 5 of 73
- Biotechnology 269
- Genetics 391
- Oncology 353
- Immunology 260
- Molecular Biology 514
Countries citing papers authored by Erkko Ylösmäki
This map shows the geographic impact of Erkko Ylösmäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkko Ylösmäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkko Ylösmäki more than expected).
Fields of papers citing papers by Erkko Ylösmäki
This network shows the impact of papers produced by Erkko Ylösmäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkko Ylösmäki. The network helps show where Erkko Ylösmäki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erkko Ylösmäki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 14 | |
| 4 | 2022 | 26 | |
| 5 | 2021 | 22 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 25 | |
| 8 | 2021 | 37 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 45 | |
| 11 | 2020 | 40 | |
| 12 | 2019 | 97 | |
| 13 | 2019 | 7 | |
| 14 | 2019 | 104 | |
| 15 | 2018 | 40 | |
| 16 | 2018 | 39 | |
| 17 | 2017 | 3 | |
| 18 | 2016 | 6 | |
| 19 | 2015 | 10 | |
| 20 | 2013 | 24 |
About Erkko Ylösmäki
Erkko Ylösmäki is a scholar working on Immunology, Genetics and Oncology, having authored 27 papers that have together received 1.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (12 papers), RNA Interference and Gene Delivery (6 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), vaccines and immunoinformatics approaches (4 papers), interferon and immune responses (2 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Biotechnology (269 citations), Genetics (391 citations) and Oncology (353 citations). Erkko Ylösmäki has collaborated with scholars based in Finland, Italy and Sweden. Frequent co-authors include Vincenzo Cerullo, Markku Saloheimo, Sara Feola, Kalle Saksela, Kristiina Kruus, Matti Siika‐aho, Laura-Leena Kiiskinen, Michael Bailey, Juha Kuja‐Panula and Michael P. Ward. Their work appears in journals such as Nature Communications, PLoS ONE and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.